MedTech & Diagnostics
Accuray Executive Compensation (FY26)
ARAY · Executive and director compensation, fiscal 2022 to 2026
Chief executive, fiscal 2026 ◇ Steve La Neve | Latest say-on-pay support = November 13, 2025 |
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.
The paid brief on Accuray
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
New filing — October 16, 2026, data updatedData as of October 19, 2026Latest filing (DEF 14A): October 16, 2026
16 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Member, one year
261 figures on this page: 251 cited to the filing that reported them, 10 calculated from figures it prints. See the citations
More on Accuray
Five data products on this company. Each one is requested through the developer setup page.
- Peer Disclosure Audit$5The comparison companies this board named, each one tied to the filing that lists it.How to get Peer Disclosure Audit
- Governance Provisions PullfreeThe governance provisions as the proxy states them: board leadership, committee membership, and shareholder rights.How to get Governance Provisions Pull
- Say-on-Pay Risk Signal$9A risk band for the next say-on-pay vote, with the support history and the peer comparison behind it.How to get Say-on-Pay Risk Signal
- NEO Comp Report$24Every named executive officer’s pay by element and year, with the citation behind each figure.How to get NEO Comp Report
- Board Comp Report$24What each non-employee director was paid, the standing fee schedule, and the equity each one holds at year end.How to get Board Comp Report
What changed from fiscal 2025 to fiscal 2026
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: Suzanne Winter → Steve La Neve
Say-on-pay support: 92.7% → 87.3% (5.4 points lower)
Frequently asked questions
Answers drawn from the data on this page.
Who is Accuray's chief executive and what were they paid?
Steve La Neve, President and Chief Executive Officer, received $5,114,466 in total compensation for fiscal 2026.
What was Accuray's say-on-pay result?
Shareholders supported the say-on-pay proposal with 87.3% of votes cast including abstentions in favor at the meeting held November 13, 2025 for fiscal 2025.
Which companies are in Accuray's peer group?
The disclosed peer group names Alphatec Holdings, Inc., AngioDynamics, Inc., Artivion, Inc., AtriCure, Inc. and Avanos Medical, Inc., among others.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Joshua Levine Former Chief Executive Officer Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Suzanne Winter President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Jesse Chew Senior Vice President, General Counsel and Corporate Secretary | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Michael Hoge Senior Vice President, Global Operations | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Brandy Green Former Interim Chief Financial Officer Departed during or after this year | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Ali Pervaiz Senior Vice President, Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Shig Hamamatsu Former Senior Vice President, Chief Financial Officer Departed during or after this year | ◇ | — | — | — | — | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Suzanne Winter President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Sandeep Chalke Senior Vice President, Chief Commercial Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Jesse Chew Senior Vice President, Chief Legal Officer and Corporate Secretary | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Ali Pervaiz Senior Vice President, Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Michael Hoge Senior Vice President, Global Operations | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Suzanne Winter President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Sandeep Chalke Senior Vice President, Chief Commercial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Jesse Chew Senior Vice President, Chief Legal Officer and Corporate Secretary | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Ali Pervaiz Senior Vice President, Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Michael Hoge Senior Vice President, Global Operations | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Suzanne Winter President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Jesse Chew Senior Vice President, Chief Legal Officer and Corporate Secretary | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Sandeep Chalke Senior Vice President, Chief Commercial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Ali Pervaiz Senior Vice President, Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2026
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Steve La Neve President and Chief Executive Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Suzanne Winter Former President and Chief Executive Officer Departed during or after this year | ◇ | — | — | — | — | — | ◇ | ◇ |
Sandeep Chalke Former Senior Vice President, Chief Commercial Officer Departed during or after this year | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Paul Miele Senior Vice President, Chief Commercial Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Ali Pervaiz Senior Vice President, Chief Financial Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Anne B. Le Grand | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Beverly A. Huss | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Byron C. Scott | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| James M. Hindman | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Joseph E. Whitters | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Mika Nishimura | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Robert C. Kill | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Steven F. Mayer | RSU | — | — | — | ◇ | — | — | ◇ |
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2026 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Ali Pervaiz | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Paul Miele | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| Steve La Neve | RSU | ◇ | ◇ | — | — |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Ali Pervaiz
Senior Vice President, Chief Financial Officer · Employment agreement · citing a 2025 filing
| Severance multiple | ◇ |
| Severance base | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Non-solicit period | ◇ |
Suzanne Winter
Former President and Chief Executive Officer · Terms as described in the company’s compensation discussion · citing a 2025 filing
| Severance multiple | ◇ |
| Severance base | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Non-solicit period | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2026
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Steven F. Mayer | ◇ | ◇ | — | — | — | ◇ | ◇ |
Anne B. Le Grand | ◇ | ◇ | — | — | — | — | ◇ |
Joseph E. Whitters Board chair | ◇ | ◇ | — | — | — | — | ◇ |
James M. Hindman | ◇ | ◇ | — | — | — | — | ◇ |
Chan W. Galbato | ◇ | ◇ | — | — | — | — | ◇ |
Beverly A. Huss | ◇ | ◇ | — | — | — | — | ◇ |
Mika Nishimura | ◇ | ◇ | — | — | — | — | ◇ |
Byron C. Scott | ◇ | ◇ | — | — | — | — | ◇ |
Robert C. Kill | ◇ | — | — | — | — | — | ◇ |
Steve La Neve and Richard A. Meier served on the board in fiscal 2026 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Equity is delivered as restricted stock units.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2026
- Alphatec Holdings, Inc. ATEC
- AngioDynamics, Inc. ANGO
- Artivion, Inc. AORT
- AtriCure, Inc. ATRC
- Avanos Medical, Inc. AVNS
- CONMED Corporation CNMD
- Cutera, Inc. CUTR
- Glaukos Corporation GKOS
- Inari Medical, Inc. NARI
- Inogen, Inc. INGN
- Inspire Medical Systems, Inc. INSP
- iRhythm Technologies, Inc. IRTC
- Lantheus Holdings, Inc. LNTH
- Merit Medical Systems, Inc. MMSI
- Nevro Corp. NVRO
- Orthofix Medical Inc. OFIX
- Penumbra, Inc. PEN
- RadNet, Inc. RDNT
- Tactile Systems Technology, Inc. TCMD
- Tandem Diabetes Care, Inc. TNDM
- Varex Imaging Corporation VREX
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | November 13, 2025 | = | ◇ | ◇ | ◇ |
| 2024 | November 21, 2024 | = | ◇ | ◇ | ◇ |
| 2023 | November 9, 2023 | = | ◇ | ◇ | ◇ |
| 2022 | November 10, 2022 | = | ◇ | ◇ | ◇ |
| 2021 | November 24, 2021 | = | ◇ | ◇ | ◇ |
| 2020 | November 20, 2020 | = | ◇ | ◇ | ◇ |
| 2019 | November 20, 2019 | = | ◇ | ◇ | ◇ |
| 2018 | November 16, 2018 | = | ◇ | ◇ | ◇ |
| 2017 | November 17, 2017 | = | ◇ | ◇ | ◇ |
| 2016 | November 17, 2016 | = | ◇ | ◇ | ◇ |
Velarion Pro: every company page, peer tools and exports, one seat
One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- Steve La Neve (President and Chief Executive Officer), FY2026 total compensation $5,114,466 (base salary $525,000) [exec_comp, SEC accession 0001140361-26-039918, filed 2026-10-16]What this page does not include
Everything above is a fact Accuray disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Accuray sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
261 figures on this page: 251 cited to the filing that reported them, 10 calculated from figures it prints.
251 cited to the filing
10 calculated from the filing
Documents cited
- 0001140361-26-039918Director Compensation Program · Fiscal 2026 Summary Compensation Table · Outstanding Equity Awards at Fiscal 2026 Year End Table
- 0001193125-25-288077Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001140361-25-036983Employment Agreement · Fiscal 2025 Summary Compensation Table · Grants of Plan-Based Awards
- 0000950170-24-130548Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001140361-24-042873Fiscal 2024 Summary Compensation Table
- 0000950170-23-064162Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001140361-23-045994Fiscal 2023 Summary Compensation Table
- 0000950170-22-025300Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001140361-22-035467Fiscal 2022 Summary Compensation Table
- 0001564590-21-058301Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001564590-20-055247Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001564590-19-043969Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-18-332357Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001104659-17-069637
- 0001104659-16-158118Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000950170-25-014485EX-10.28
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Accuray executive compensation, FY2022–FY2026.” https://intel.velarion.ai/comp/ARAY (accessed 2026).
Short form: data: Velarion
The paid brief for Accuray
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
16 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Accuray and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
MedTech & Diagnostics rankings
Peers Accuray discloses
The companies named in ARAY's own disclosed peer group.
Alphatec Holdings, Inc.AngioDynamics, Inc.Artivion, Inc.AtriCure, Inc.Avanos Medical, Inc.CONMED CorporationCutera, Inc.Glaukos CorporationInari Medical, Inc.Inogen, Inc.Inspire Medical Systems, Inc.iRhythm Technologies, Inc.Lantheus Holdings, Inc.Merit Medical Systems, Inc.Nevro Corp.Orthofix Medical Inc.Penumbra, Inc.RadNet, Inc.Tactile Systems Technology, Inc.Tandem Diabetes Care, Inc.Varex Imaging Corporation
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}